News

BioMed SA eyes new road map to greater economic wins

BioMed SA President Ann Stevens (Photo by Lyndsey Johnson) By W. Scott Bailey, San Antonio Business ...

Diabetes, Infectious Diseases Early Focus of San Antonio Biomed Plan

David Holley, Xconomy Texas —  San Antonio — [Updated 12/14/17, 11:54 p.m. See below.] ...

Industry Publications

The Mission

The Mission is published by the University of Texas Health Science Center.

UTSA Discovery

UTSA Discovery is published annually for the Office of the Vice President for Research by the Office ...

News
SA-based global biotech company taps former KCI executive for new CEO
September 19, 2016

Martin Landon will become the new CEO of BioBridge Global on Oct. 1. COURTESY OF BIOBRIDGE GLOBAL

W. Scott Bailey
Reporter/Project Coordinator
San Antonio Business Journal

BioBridge Global has named Martin Landon as its new CEO, as yet Another San Antonio bioscience company has turned to former Kinetic Concepts Inc. talent to fill a key leadership position.

Landon spent nearly two decades at KCI, where he was controller and then chief financial officer. Since 2014, he has been president and CEO at CeloNova BioSciences Inc., an early-stage, global medical device company focusing on interventional cardiology and endovascular products.

Last year, on Landon's watch, CeloNova made headlines when the company sold its interventional radiology business to Boston Scientific. He will retain a position on CeloNova's board of directors.

Landon will join BioBridge Global on Oct. 1. He will succeed Linda Myers, who informed the company's board this summer of her plan to step down by the end of the year.

Myers became president and CEO of BioBridge Global in 2013, when the holding company was created to oversee the South Texas Blood & Tissue Center, QualTex Laboratories, GenCure and The Blood and Tissue Center Foundation. She has played a critical role in raising San Antonio's profile in the bioscience arena nationally and internationally, helping the city land the World Stem Cell Summit in 2014.

"I've been with the organization for 22 years - all in leadership roles. I'm approaching the last few months of my five-year contract with BioBridge Global, and in talking with the board, we thought now would be a really good time to step out there and look for a successor," Myers told me in July. "Since I'm getting toward the end of my career, it was time to start looking for the next generation of leadership to carry this forward."

Myers will work with Landon through October to facilitate a smooth transition in leadership, BioBridge Global Chairman Mike Kreager said.

Kreager told me soon after I reported on Myers' planned exit that he was hopeful the company could find her successor here in San Antonio.

 

 

Stay informed. Subscribe to BioMed SA news alerts.